William Peterson
Neurology · Washington, DCNPI 1144419227
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.7% of the total across 126 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Supernus Pharmaceuticals, Inc. at 50.2% of the total. Reporting peaked in 2020 at $1,157 and has fallen 95.0% since, to $58 in 2022.
Across 126 payments — averaging $18.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$1K
- Novartis$205
- Sunovion Pharmaceuticals Inc.$183
- E.r. Squibb & Sons, L.L.C.$131
- Mallinckrodt Hospital Products Inc.$130
- EMD Serono, Inc.$99
- plus $394 from 10 others
Across 5 payments — averaging $12,370 each. An ownership or investment interest held by the physician or an immediate family member.
- Centerline Biomedical Inc.$62K
What the payments were for
- Food & beverage$2,26599%
- Education$301%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 61 | $1,152 |
| Novartis | 13 | $205 |
| Sunovion Pharmaceuticals Inc. | 10 | $183 |
| E.r. Squibb & Sons, L.L.C. | 7 | $131 |
| Mallinckrodt Hospital Products Inc. | 6 | $130 |
| EMD Serono, Inc. | 6 | $99 |
| Genentech USA, Inc. | 5 | $93 |
| Biogen | 4 | $74 |
| Scilex Pharmaceuticals Inc. | 4 | $54 |
| Avanir Pharmaceuticals, Inc. | 3 | $37 |
| Johnson & Johnson | 1 | $30 |
| Sanofi | 2 | $29 |
| Eisai Inc. | 1 | $24 |
| AstraZeneca | 1 | $20 |
| Mallinckrodt Enterprises LLC | 1 | $19 |
| Avion Pharmaceuticals | 1 | $13 |
How this compares
$2,295 in reported general payments places this provider in the 60th percentile of 113 neurology providers in District of Columbia.
Other neurology in Washington
- Laxman BahrooWashington$3.1M
- Fahd AmjadWashington$2M
- Jessica AilaniWashington$1.2M
- Yasar Torres-YaghiWashington$969K
- Benjamin OsborneWashington$747K
- Fernando PaganWashington$690K
- Faria AmjadWashington$557K
- Brian BarryWashington$359K
- Carrie DoughertyWashington$327K
- Carlo TornatoreWashington$318K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.